February 6, 2024
Launches first commercial platform, the UG 100TM, targeting the high-throughput market and enabling commercial availability of the $100 genome Showcases substantial improvements in indel accuracy with 99.4% INDEL F1 score and an expanded high confidence region Reveals 1 in 1,000,000 raw read error rates for SNVs, or Q60-level accuracy, with new ppmSeqTM technology enabled by Ultima’s [...]
February 6, 2024
Increased level of Indian customer support through new partnership Berlin -- The partnership between Berlin-based LUM GmbH and the Indian company VENTURE INSTRUMENTATION TECHNOLOGIES PVT LTD. (VENTURE) started on February 1, 2024. VENTURE is based in Bangalore, the centre of India's high-tech industry, in the state of Karnataka. Susanne Lerche-Merchant, CEO of LUM GmbH: “LUM [...]
February 6, 2024
King of Prussia, PA, US and Waltham, MA, US – Purolite, an Ecolab company a leading manufacturer of synthetic and agarose-based bioprocessing resins, and Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of Praesto® CH1, a new 70μm (micron) agarose-based affinity resin designed to purify specialized [...]
Volta Labs and Watchmaker Genomics Partner to Simplify and Optimize NGS Library Prep
February 5, 2024
BOSTON, MA and BOULDER, CO – Volta Labs, a genomics applications company, and Watchmaker Genomics, a supplier of innovative products for molecular analysis, partner to leverage their technologies to power Volta’s short-read library prep kits. Volta Labs and Watchmaker Genomics are jointly committed to making efficient, accessible, and cost-effective library prep a reality. With the launch of Volta’s [...]
Element to Present Data on New Products and Multi-Omics Capabilities at AGBT
February 5, 2024
Element will share results from the industry’s first commercial Q50 sequencing kit Element’s customers report how innovative methods available on the AVITI out-perform legacy devices SAN DIEGO, CA – Element Biosciences, Inc., developer of pioneering technologies to empower science, will present details on five new products launching in 2024 at the Advances in Genome Biology and [...]
February 5, 2024
The collaboration aims to continue to gain commercial traction after Nabsys announced the OhmX platform in October 2023. Providence, Rhode Island – Hitachi High-Tech America, Inc. (“HTA”), in conjunction with Nabsys, announces a strategic leap forward in genomics research through HTA’s planned acquisition of 50 OhmX instruments to support the joint “RAMP UP” program. RAMP [...]
February 5, 2024
New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a series of new products and technology demonstrations that will be presented at the 2024 Advances in [...]
February 5, 2024
Addition of another amino acid recognizer combined with improvements in surface chemistry, reagents and software will offer Platinum users greater sequencing output and coverage per sample BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the launch of new platform enhancements for Platinum®, with the release of [...]
biomodal delivers the 6-base genome with a powerful new multiomic solution, duet evoC
February 5, 2024
Novel solution distinguishes 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample CAMBRIDGE, UK – biomodal, an omics-based life sciences technology and analytics company, today announced it’s delivering the 6-base genome to customers with the launch of duet multiomics solution evoC (duet evoC). The combinatorial [...]
February 5, 2024
DURHAM, NORTH CAROLINA, UNITED STATES — Cell Microsystems, a leading provider of advanced tools for cell biology, is excited to announce a strategic partnership with OMNI Life Science (OLS), a renowned German cell biology company. This collaboration aims to introduce three revolutionary products – the CERO, CASY, and TIGR – to the United States and Canadian markets, [...]

